Endo, Inc. Files 10-Q for Q1 2025
| Field | Detail |
|---|---|
| Company | Endo, Inc. |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, SEC filing
TL;DR
Endo Inc. 10-Q filed for Q1 2025. Financials are in.
AI Summary
Endo, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. Key financial data and disclosures are presented as required by SEC regulations.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Endo, Inc., crucial for understanding the company's current standing.
Risk Assessment
Risk Level: medium — The filing is a standard 10-Q, but the company's industry and financial health can present inherent risks.
Key Players & Entities
- Endo, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250512 (date) — Filing date
- 9 GREAT VALLEY PARKWAY, MALVERN, PA 19355 (address) — Company's business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the first quarter of 2025.
When was this 10-Q filed with the SEC?
The filing date is 20250512.
What is Endo, Inc.'s Standard Industrial Classification code?
Endo, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's state of incorporation?
Endo, Inc. is incorporated in Delaware (DE).
What is the business phone number listed for Endo, Inc.?
The business phone number is (484) 216-0000.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Endo, Inc..